$MDXG said that Dr. I. Mark Landy has joined as the company's VP responsible for key strategic initiatives. In his new role, Mark will support certain domestic and international strategic imperatives and related growth initiatives. Mark will report to Chairman and CEO Parker H. Petit.
$TGT's sales for 4Q16 decreased 4.3% from last year, reflecting a 1.5% decline in comparable sales combined with with the removal of pharmacy and clinic sales from this year's results. Comparable digital channel sales grew 34% and contributed 1.8 percentage points of comparable sales growth.
$TGT reported a 42.7% drop in 4Q16 earnings due to the impact of rapidly-changing consumer behavior, which drove very strong digital growth but unexpected softness in stores. Net income fell to $817MM or $1.45 per share from $1.43Bil or $2.32 per share last year. Sales declined 4.3% to $20.69Bil. Adjusted EPS decreased 4.6% to $1.45.